Last updated: May 26, 2026
Suppliers for INVELTYS (inveltys) eye drops: Who manufactures the drug product and supplies contract services?
INVELTYS (loteprednol etabonate ophthalmic suspension) is sourced through a vertically integrated, contract-manufacturing and contract-packaging network typical for ophthalmic branded products. The specific supplier identities for INVELTYS drug product, fill-finish, and packaging are not provided in the available dataset in this session, so a complete, supplier-specific mapping cannot be produced.
What suppliers make INVELTYS (loteprednol etabonate) drug product?
No supplier-level manufacturing details for INVELTYS (drug substance, drug product, fill-finish, or packaging) are available in the provided information for this task.
What is the typical supply chain for loteprednol ophthalmic suspensions?
Common industry roles include drug substance synthesis (active ingredient makers), sterile ophthalmic suspension manufacturing, aseptic fill-finish (or controlled non-sterile processing depending on product specifics), and secondary packaging. For INVELTYS, the exact named vendors are not available here.
Who provides INVELTYS manufacturing under contract?
No contract-manufacturing supplier names for INVELTYS are available in the provided information.
Are there known contract manufacturers for INVELTYS?
Not in the available dataset in this session.
Which companies supply INVELTYS packaging and labeling?
No packaging and labeling suppliers for INVELTYS are available in the provided information.
What components are sourced for INVELTYS eye drops?
Typical components include ophthalmic bottle or dropper system, sterile contact surfaces (where applicable), carton and leaflet, and serialized labeling components. Specific INVELTYS supplier names are not provided here.
How can you identify INVELTYS suppliers from regulatory records?
INVELTYS suppliers can often be identified via FDA facility listings, CMC sections, and inspection histories tied to the NDA holder’s manufacturing sites. The required site-specific facility and dossier identifiers are not available in the provided information here, so a supplier list cannot be compiled.
What filings usually list manufacturing sites?
- FDA drug application (NDA) manufacturing site sections
- Labeling and package insert “Manufactured for” / “Distributed by” blocks
- Inspections and facility registration records tied to the marketing application
What does INVELTYS’ Orange Book status imply for supplier access?
Orange Book status informs patent and exclusivity, not direct supplier identity. Supplier-level manufacturing details for INVELTYS are not present in the provided information.
What generic or biosimilar entry risks affect INVELTYS supply?
INVELTYS is an ophthalmic corticosteroid product and is not a biologic, so “biosimilar” framing is not applicable. Specific competitors or approved generic/AB-rated products, and their manufacturing networks, are not available in the provided information here.
How do licensing deals change INVELTYS supplier relationships?
Licensing typically changes rights to manufacture and distribute but does not automatically reveal named contract suppliers without dossier- or facility-level data. No licensing deal details tied to INVELTYS supply chain are available in the provided information.
Key Takeaways
- Named suppliers for INVELTYS drug product, fill-finish, packaging, and labeling are not available in the information provided in this session.
- A supplier-specific mapping cannot be produced without FDA/labeling/facility identifiers.
FAQs
1) Who is the manufacturer of INVELTYS?
Not available from the provided information in this session.
2) Which companies fill-finish INVELTYS ophthalmic suspension?
Not available from the provided information in this session.
3) What company supplies the packaging for INVELTYS?
Not available from the provided information in this session.
4) Can INVELTYS suppliers be confirmed via the FDA database?
Supplier confirmation requires facility and filing identifiers that are not available in the provided information in this session.
5) Are INVELTYS generics likely to use the same suppliers?
No supplier-specific competitor information is available in the provided information in this session.
References
No sources were cited because no supplier-identifying information was available in the provided dataset for this response.
